Share Price and Basic Stock Data
Last Updated: November 12, 2025, 3:45 am
| PEG Ratio | 0.50 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Nucleus Software Exports Ltd, operating in the IT Consulting & Software sector, reported a market capitalization of ₹2,721 Cr and a share price of ₹1,016. The company’s revenue from operations has displayed a robust growth trajectory, increasing from ₹497 Cr in FY 2022 to ₹634 Cr in FY 2023, and further projected to reach ₹832 Cr in FY 2025. The quarterly sales figures indicate a consistent upward trend, with revenues reaching ₹206 Cr in Mar 2024 and ₹210 Cr in Mar 2025. The last reported quarterly sales for Jun 2025 stood at ₹218 Cr. This growth reflects the company’s strategic positioning in a growing sector, where IT consulting and software solutions are in high demand, especially post-pandemic as businesses increasingly digitize their operations.
Profitability and Efficiency Metrics
Nucleus Software’s profitability metrics reveal an operating profit margin (OPM) of 20% for FY 2025, indicating solid operational efficiency. The net profit for the same year recorded at ₹163 Cr, with an impressive net profit margin of 19.58%. This is a notable improvement from ₹41 Cr and an 8.22% margin reported in FY 2022. The return on equity (ROE) stood at 20.01% and return on capital employed (ROCE) at 25.25% for FY 2025, showcasing effective capital utilization. The interest coverage ratio (ICR) was remarkably high at 312.81x, reflecting the company’s ability to comfortably cover its interest obligations. However, the cash conversion cycle (CCC) has shown an increase to 60 days, suggesting potential inefficiencies in working capital management that could affect liquidity.
Balance Sheet Strength and Financial Ratios
The balance sheet of Nucleus Software demonstrates a strong financial position, with total assets of ₹1,153 Cr and total liabilities at ₹1,153 Cr as of FY 2025. The company has maintained minimal borrowings of ₹2 Cr, indicating prudent financial management and low leverage. Reserves increased to ₹788 Cr, providing a buffer for future investments and stability. The company’s price-to-book value (P/BV) ratio stood at 2.59x, which is relatively high compared to typical sector ranges, suggesting a premium valuation. The liquidity ratios also reflect a healthy financial state, with a current ratio of 1.93x and quick ratio of 1.93x, indicating adequate short-term asset coverage for liabilities. However, the declining trend in net profit from ₹192 Cr in FY 2024 to ₹163 Cr in FY 2025 raises questions about future profitability sustainability.
Shareholding Pattern and Investor Confidence
Nucleus Software’s shareholding structure reveals a strong promoter holding of 73.59%, which underscores significant insider confidence in the company’s long-term prospects. Foreign institutional investors (FIIs) hold 5.32%, and domestic institutional investors (DIIs) account for 1.47%, indicating moderate institutional interest. The public shareholding comprises 19.60%, with a total of 42,545 shareholders as of Jun 2025. The gradual increase in promoter holding from 73.27% in Sep 2022 to the current level suggests a robust commitment by the founders to the company’s growth. However, the slight decline in FIIs from a peak of 5.65% in Mar 2024 to 5.32% may reflect cautious sentiment among foreign investors amidst market volatility. This mixed sentiment could influence future stock performance and investor confidence.
Outlook, Risks, and Final Insight
The outlook for Nucleus Software appears cautiously optimistic, with strong revenue growth and profitability metrics indicating potential for continued expansion in the IT sector. However, risks remain, particularly regarding the company’s increasing cash conversion cycle and declining net profit, which could impact operational efficiency and investor sentiment. Additionally, the competitive landscape within the IT consulting space poses a persistent challenge, as companies vie for market share in a rapidly evolving environment. Should Nucleus Software successfully address these operational inefficiencies and maintain its growth trajectory, it may well capitalize on the digital transformation trend among enterprises. Conversely, failure to manage these risks could hinder its financial performance and market position.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Nucleus Software Exports Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | 0.38/0.33 | 1.12 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 36.9 Cr. | 11.7 | 11.7/4.43 | 0.25 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| IDream Film Infrastructure Company Ltd | 2.78 Cr. | 185 | 185/98.4 | 302 | 0.00 % | % | % | 10.0 | |
| I Power Solutions India Ltd | 12.5 Cr. | 21.2 | 21.2/14.4 | 7.82 | 0.00 % | 11.6 % | 16.9 % | 10.0 | |
| Hypersoft Technologies Ltd | 42.8 Cr. | 101 | 101/17.6 | 40.4 | 5.69 | 0.00 % | 20.6 % | 9.07 % | 10.0 |
| Industry Average | 117,696.63 Cr | 768.94 | 46.30 | 143.07 | 0.69% | 20.11% | 21.05% | 6.56 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 129 | 130 | 169 | 206 | 207 | 205 | 204 | 210 | 195 | 202 | 206 | 229 | 218 |
| Expenses | 114 | 119 | 121 | 123 | 144 | 153 | 156 | 152 | 166 | 170 | 172 | 154 | 184 |
| Operating Profit | 15 | 11 | 48 | 83 | 63 | 52 | 48 | 58 | 29 | 32 | 33 | 74 | 34 |
| OPM % | 11% | 9% | 28% | 40% | 30% | 25% | 23% | 28% | 15% | 16% | 16% | 33% | 16% |
| Other Income | 6 | 9 | 9 | 10 | 13 | 12 | 12 | 14 | 15 | 19 | 16 | 17 | 18 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 |
| Profit before tax | 16 | 15 | 52 | 89 | 72 | 60 | 56 | 68 | 40 | 47 | 45 | 88 | 48 |
| Tax % | 31% | 26% | 26% | 24% | 25% | 26% | 26% | 24% | 24% | 29% | 22% | 26% | 27% |
| Net Profit | 11 | 11 | 38 | 68 | 54 | 45 | 41 | 52 | 30 | 33 | 35 | 65 | 35 |
| EPS in Rs | 4.02 | 4.12 | 14.32 | 25.27 | 20.01 | 16.65 | 15.43 | 19.47 | 11.28 | 12.35 | 13.06 | 24.19 | 13.15 |
Last Updated: August 1, 2025, 4:15 pm
Below is a detailed analysis of the quarterly data for Nucleus Software Exports Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 218.00 Cr.. The value appears to be declining and may need further review. It has decreased from 229.00 Cr. (Mar 2025) to 218.00 Cr., marking a decrease of 11.00 Cr..
- For Expenses, as of Jun 2025, the value is 184.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 154.00 Cr. (Mar 2025) to 184.00 Cr., marking an increase of 30.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 34.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 40.00 Cr..
- For OPM %, as of Jun 2025, the value is 16.00%. The value appears to be declining and may need further review. It has decreased from 33.00% (Mar 2025) to 16.00%, marking a decrease of 17.00%.
- For Other Income, as of Jun 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 88.00 Cr. (Mar 2025) to 48.00 Cr., marking a decrease of 40.00 Cr..
- For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Mar 2025) to 27.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2025, the value is 35.00 Cr.. The value appears to be declining and may need further review. It has decreased from 65.00 Cr. (Mar 2025) to 35.00 Cr., marking a decrease of 30.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 13.15. The value appears to be declining and may need further review. It has decreased from 24.19 (Mar 2025) to 13.15, marking a decrease of 11.04.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 2:21 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 346 | 353 | 349 | 372 | 412 | 484 | 521 | 514 | 497 | 634 | 826 | 832 | 855 |
| Expenses | 278 | 287 | 318 | 319 | 353 | 405 | 427 | 384 | 460 | 478 | 606 | 664 | 681 |
| Operating Profit | 68 | 66 | 31 | 54 | 59 | 79 | 94 | 129 | 37 | 157 | 220 | 168 | 173 |
| OPM % | 20% | 19% | 9% | 14% | 14% | 16% | 18% | 25% | 7% | 25% | 27% | 20% | 20% |
| Other Income | 24 | 33 | 26 | 32 | 29 | 27 | 37 | 39 | 35 | 34 | 51 | 66 | 69 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 8 | 12 | 12 | 11 | 7 | 10 | 14 | 14 | 15 | 19 | 15 | 15 | 14 |
| Profit before tax | 83 | 87 | 44 | 74 | 80 | 96 | 117 | 154 | 56 | 171 | 256 | 219 | 227 |
| Tax % | 23% | 25% | 26% | 11% | 22% | 23% | 24% | 23% | 26% | 25% | 25% | 26% | |
| Net Profit | 64 | 65 | 32 | 66 | 63 | 75 | 89 | 118 | 41 | 128 | 192 | 163 | 168 |
| EPS in Rs | 19.87 | 19.98 | 10.03 | 20.43 | 21.54 | 25.67 | 30.64 | 40.62 | 15.28 | 47.73 | 71.56 | 60.88 | 62.75 |
| Dividend Payout % | 30% | 25% | 50% | 24% | 37% | 35% | 29% | 22% | 46% | 21% | 17% | 20% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 1.56% | -50.77% | 106.25% | -4.55% | 19.05% | 18.67% | 32.58% | -65.25% | 212.20% | 50.00% | -15.10% |
| Change in YoY Net Profit Growth (%) | 0.00% | -52.33% | 157.02% | -110.80% | 23.59% | -0.38% | 13.92% | -97.84% | 277.45% | -162.20% | -65.10% |
Nucleus Software Exports Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 19% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 72% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 15% |
| 3 Years: | 36% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 17% |
| 3 Years: | 20% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 11:50 am
Balance Sheet
Last Updated: June 16, 2025, 11:36 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32 | 32 | 32 | 32 | 29 | 29 | 29 | 29 | 27 | 27 | 27 | 26 |
| Reserves | 365 | 406 | 425 | 503 | 432 | 480 | 532 | 643 | 467 | 584 | 751 | 788 |
| Borrowings | 0 | 0 | 1 | 0 | 0 | 0 | 6 | 6 | 2 | 6 | 5 | 2 |
| Other Liabilities | 116 | 118 | 123 | 131 | 184 | 177 | 196 | 206 | 241 | 257 | 332 | 337 |
| Total Liabilities | 513 | 556 | 581 | 665 | 645 | 685 | 763 | 885 | 737 | 874 | 1,114 | 1,153 |
| Fixed Assets | 61 | 58 | 54 | 48 | 48 | 47 | 57 | 50 | 59 | 50 | 59 | 61 |
| CWIP | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 |
| Investments | 224 | 170 | 245 | 441 | 387 | 424 | 475 | 635 | 480 | 525 | 649 | 641 |
| Other Assets | 228 | 328 | 281 | 176 | 210 | 214 | 231 | 200 | 198 | 298 | 406 | 451 |
| Total Assets | 513 | 556 | 581 | 665 | 645 | 685 | 763 | 885 | 737 | 874 | 1,114 | 1,153 |
Below is a detailed analysis of the balance sheet data for Nucleus Software Exports Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Mar 2024) to 26.00 Cr., marking a decrease of 1.00 Cr..
- For Reserves, as of Mar 2025, the value is 788.00 Cr.. The value appears strong and on an upward trend. It has increased from 751.00 Cr. (Mar 2024) to 788.00 Cr., marking an increase of 37.00 Cr..
- For Borrowings, as of Mar 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 5.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 3.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 337.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 332.00 Cr. (Mar 2024) to 337.00 Cr., marking an increase of 5.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,153.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,114.00 Cr. (Mar 2024) to 1,153.00 Cr., marking an increase of 39.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 61.00 Cr.. The value appears strong and on an upward trend. It has increased from 59.00 Cr. (Mar 2024) to 61.00 Cr., marking an increase of 2.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Investments, as of Mar 2025, the value is 641.00 Cr.. The value appears to be declining and may need further review. It has decreased from 649.00 Cr. (Mar 2024) to 641.00 Cr., marking a decrease of 8.00 Cr..
- For Other Assets, as of Mar 2025, the value is 451.00 Cr.. The value appears strong and on an upward trend. It has increased from 406.00 Cr. (Mar 2024) to 451.00 Cr., marking an increase of 45.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,153.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,114.00 Cr. (Mar 2024) to 1,153.00 Cr., marking an increase of 39.00 Cr..
Notably, the Reserves (788.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 68.00 | 66.00 | 30.00 | 54.00 | 59.00 | 79.00 | 88.00 | 123.00 | 35.00 | 151.00 | 215.00 | 166.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 44 | 87 | 90 | 60 | 70 | 54 | 63 | 63 | 61 | 100 | 73 | 60 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 44 | 87 | 90 | 60 | 70 | 54 | 63 | 63 | 61 | 100 | 73 | 60 |
| Working Capital Days | -5 | 14 | 7 | -43 | -66 | -51 | -53 | -61 | -77 | -16 | -38 | -43 |
| ROCE % | 21% | 19% | 10% | 15% | 16% | 19% | 21% | 22% | 6% | 27% | 32% | 23% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| WhiteOak Capital Flexi Cap Fund | 113,333 | 0.63 | 16.66 | 113,333 | 2025-04-22 17:25:24 | 0% |
| ICICI Prudential Innovation Fund | 65,999 | 0.3 | 9.7 | 65,999 | 2025-04-22 17:25:24 | 0% |
| WhiteOak Capital Mid Cap Fund | 45,586 | 0.51 | 6.7 | 45,586 | 2025-04-22 17:25:24 | 0% |
| Quant Teck Fund | 38,000 | 2.75 | 5.58 | 38,000 | 2025-04-22 17:25:24 | 0% |
| WhiteOak Capital Multi Cap Fund | 25,166 | 0.71 | 3.7 | 25,166 | 2025-04-22 17:25:24 | 0% |
| WhiteOak Capital Large Cap Fund | 11,472 | 0.46 | 1.69 | 11,472 | 2025-04-22 17:25:24 | 0% |
| WhiteOak Capital Balanced Advantage Fund | 8,909 | 0.18 | 1.31 | 8,909 | 2025-04-22 17:25:24 | 0% |
| ICICI Prudential Technology Fund | 6,651 | 0.01 | 0.98 | 6,651 | 2025-04-22 17:25:24 | 0% |
| WhiteOak Capital ELSS Tax Saver Fund | 4,324 | 0.58 | 0.64 | 4,324 | 2025-04-22 17:25:24 | 0% |
| WhiteOak Capital Multi Asset Allocation Fund | 1,716 | 0.1 | 0.25 | 1,716 | 2025-04-22 17:25:24 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 61.40 | 71.56 | 47.73 | 14.28 | 40.62 |
| Diluted EPS (Rs.) | 61.40 | 71.56 | 47.73 | 14.28 | 40.62 |
| Cash EPS (Rs.) | 67.53 | 77.01 | 54.73 | 21.03 | 45.39 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 309.24 | 290.41 | 228.11 | 184.38 | 231.41 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 309.24 | 290.41 | 228.11 | 184.38 | 231.41 |
| Revenue From Operations / Share (Rs.) | 316.08 | 308.72 | 237.00 | 185.73 | 176.84 |
| PBDIT / Share (Rs.) | 89.10 | 101.34 | 71.28 | 26.78 | 58.16 |
| PBIT / Share (Rs.) | 83.48 | 95.91 | 64.29 | 21.03 | 53.38 |
| PBT / Share (Rs.) | 83.19 | 95.55 | 63.91 | 20.73 | 52.96 |
| Net Profit / Share (Rs.) | 61.91 | 71.57 | 47.74 | 15.28 | 40.62 |
| NP After MI And SOA / Share (Rs.) | 61.91 | 71.57 | 47.74 | 15.28 | 40.62 |
| PBDIT Margin (%) | 28.18 | 32.82 | 30.07 | 14.41 | 32.88 |
| PBIT Margin (%) | 26.41 | 31.06 | 27.12 | 11.32 | 30.18 |
| PBT Margin (%) | 26.32 | 30.95 | 26.96 | 11.16 | 29.95 |
| Net Profit Margin (%) | 19.58 | 23.18 | 20.14 | 8.22 | 22.96 |
| NP After MI And SOA Margin (%) | 19.58 | 23.18 | 20.14 | 8.22 | 22.96 |
| Return on Networth / Equity (%) | 20.01 | 24.64 | 20.92 | 8.28 | 17.55 |
| Return on Capital Employeed (%) | 25.25 | 31.36 | 26.84 | 10.84 | 22.57 |
| Return On Assets (%) | 14.13 | 17.19 | 14.61 | 5.55 | 13.33 |
| Asset Turnover Ratio (%) | 0.73 | 0.83 | 0.74 | 0.56 | 0.56 |
| Current Ratio (X) | 1.93 | 2.07 | 2.07 | 2.09 | 3.11 |
| Quick Ratio (X) | 1.93 | 2.07 | 2.07 | 2.09 | 3.11 |
| Dividend Payout Ratio (NP) (%) | 20.53 | 13.97 | 14.66 | 42.58 | 7.38 |
| Dividend Payout Ratio (CP) (%) | 18.82 | 12.98 | 12.79 | 30.94 | 6.60 |
| Earning Retention Ratio (%) | 79.47 | 86.03 | 85.34 | 57.42 | 92.62 |
| Cash Earning Retention Ratio (%) | 81.18 | 87.02 | 87.21 | 69.06 | 93.40 |
| Interest Coverage Ratio (X) | 312.81 | 285.58 | 187.09 | 88.51 | 138.44 |
| Interest Coverage Ratio (Post Tax) (X) | 218.33 | 202.68 | 126.28 | 51.51 | 97.68 |
| Enterprise Value (Cr.) | 1988.60 | 3091.48 | 1658.15 | 1054.42 | 1353.67 |
| EV / Net Operating Revenue (X) | 2.39 | 3.74 | 2.61 | 2.12 | 2.64 |
| EV / EBITDA (X) | 8.48 | 11.40 | 8.69 | 14.71 | 8.01 |
| MarketCap / Net Operating Revenue (X) | 2.54 | 3.83 | 2.69 | 2.23 | 2.72 |
| Retention Ratios (%) | 79.46 | 86.02 | 85.33 | 57.41 | 92.61 |
| Price / BV (X) | 2.59 | 4.07 | 2.80 | 2.25 | 2.08 |
| Price / Net Operating Revenue (X) | 2.54 | 3.83 | 2.69 | 2.23 | 2.72 |
| EarningsYield | 0.07 | 0.06 | 0.07 | 0.03 | 0.08 |
After reviewing the key financial ratios for Nucleus Software Exports Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 61.40. This value is within the healthy range. It has decreased from 71.56 (Mar 24) to 61.40, marking a decrease of 10.16.
- For Diluted EPS (Rs.), as of Mar 25, the value is 61.40. This value is within the healthy range. It has decreased from 71.56 (Mar 24) to 61.40, marking a decrease of 10.16.
- For Cash EPS (Rs.), as of Mar 25, the value is 67.53. This value is within the healthy range. It has decreased from 77.01 (Mar 24) to 67.53, marking a decrease of 9.48.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 309.24. It has increased from 290.41 (Mar 24) to 309.24, marking an increase of 18.83.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 309.24. It has increased from 290.41 (Mar 24) to 309.24, marking an increase of 18.83.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 316.08. It has increased from 308.72 (Mar 24) to 316.08, marking an increase of 7.36.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 89.10. This value is within the healthy range. It has decreased from 101.34 (Mar 24) to 89.10, marking a decrease of 12.24.
- For PBIT / Share (Rs.), as of Mar 25, the value is 83.48. This value is within the healthy range. It has decreased from 95.91 (Mar 24) to 83.48, marking a decrease of 12.43.
- For PBT / Share (Rs.), as of Mar 25, the value is 83.19. This value is within the healthy range. It has decreased from 95.55 (Mar 24) to 83.19, marking a decrease of 12.36.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 61.91. This value is within the healthy range. It has decreased from 71.57 (Mar 24) to 61.91, marking a decrease of 9.66.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 61.91. This value is within the healthy range. It has decreased from 71.57 (Mar 24) to 61.91, marking a decrease of 9.66.
- For PBDIT Margin (%), as of Mar 25, the value is 28.18. This value is within the healthy range. It has decreased from 32.82 (Mar 24) to 28.18, marking a decrease of 4.64.
- For PBIT Margin (%), as of Mar 25, the value is 26.41. This value exceeds the healthy maximum of 20. It has decreased from 31.06 (Mar 24) to 26.41, marking a decrease of 4.65.
- For PBT Margin (%), as of Mar 25, the value is 26.32. This value is within the healthy range. It has decreased from 30.95 (Mar 24) to 26.32, marking a decrease of 4.63.
- For Net Profit Margin (%), as of Mar 25, the value is 19.58. This value exceeds the healthy maximum of 10. It has decreased from 23.18 (Mar 24) to 19.58, marking a decrease of 3.60.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 19.58. This value is within the healthy range. It has decreased from 23.18 (Mar 24) to 19.58, marking a decrease of 3.60.
- For Return on Networth / Equity (%), as of Mar 25, the value is 20.01. This value is within the healthy range. It has decreased from 24.64 (Mar 24) to 20.01, marking a decrease of 4.63.
- For Return on Capital Employeed (%), as of Mar 25, the value is 25.25. This value is within the healthy range. It has decreased from 31.36 (Mar 24) to 25.25, marking a decrease of 6.11.
- For Return On Assets (%), as of Mar 25, the value is 14.13. This value is within the healthy range. It has decreased from 17.19 (Mar 24) to 14.13, marking a decrease of 3.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.73. It has decreased from 0.83 (Mar 24) to 0.73, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has decreased from 2.07 (Mar 24) to 1.93, marking a decrease of 0.14.
- For Quick Ratio (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has decreased from 2.07 (Mar 24) to 1.93, marking a decrease of 0.14.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.53. This value is within the healthy range. It has increased from 13.97 (Mar 24) to 20.53, marking an increase of 6.56.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 18.82. This value is below the healthy minimum of 20. It has increased from 12.98 (Mar 24) to 18.82, marking an increase of 5.84.
- For Earning Retention Ratio (%), as of Mar 25, the value is 79.47. This value exceeds the healthy maximum of 70. It has decreased from 86.03 (Mar 24) to 79.47, marking a decrease of 6.56.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 81.18. This value exceeds the healthy maximum of 70. It has decreased from 87.02 (Mar 24) to 81.18, marking a decrease of 5.84.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 312.81. This value is within the healthy range. It has increased from 285.58 (Mar 24) to 312.81, marking an increase of 27.23.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 218.33. This value is within the healthy range. It has increased from 202.68 (Mar 24) to 218.33, marking an increase of 15.65.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,988.60. It has decreased from 3,091.48 (Mar 24) to 1,988.60, marking a decrease of 1,102.88.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.39. This value is within the healthy range. It has decreased from 3.74 (Mar 24) to 2.39, marking a decrease of 1.35.
- For EV / EBITDA (X), as of Mar 25, the value is 8.48. This value is within the healthy range. It has decreased from 11.40 (Mar 24) to 8.48, marking a decrease of 2.92.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.54. This value is within the healthy range. It has decreased from 3.83 (Mar 24) to 2.54, marking a decrease of 1.29.
- For Retention Ratios (%), as of Mar 25, the value is 79.46. This value exceeds the healthy maximum of 70. It has decreased from 86.02 (Mar 24) to 79.46, marking a decrease of 6.56.
- For Price / BV (X), as of Mar 25, the value is 2.59. This value is within the healthy range. It has decreased from 4.07 (Mar 24) to 2.59, marking a decrease of 1.48.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.54. This value is within the healthy range. It has decreased from 3.83 (Mar 24) to 2.54, marking a decrease of 1.29.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Nucleus Software Exports Ltd:
- Net Profit Margin: 19.58%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 25.25% (Industry Average ROCE: 19.31%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 20.01% (Industry Average ROE: 19.37%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 218.33
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.93
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 16.3 (Industry average Stock P/E: 35.19)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 19.58%
FAQ
What is the intrinsic value of Nucleus Software Exports Ltd?
Nucleus Software Exports Ltd's intrinsic value (as of 12 November 2025) is 674.44 which is 31.25% lower the current market price of 981.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 2,626 Cr. market cap, FY2025-2026 high/low of 1,378/724, reserves of ₹788 Cr, and liabilities of 1,153 Cr.
What is the Market Cap of Nucleus Software Exports Ltd?
The Market Cap of Nucleus Software Exports Ltd is 2,626 Cr..
What is the current Stock Price of Nucleus Software Exports Ltd as on 12 November 2025?
The current stock price of Nucleus Software Exports Ltd as on 12 November 2025 is 981.
What is the High / Low of Nucleus Software Exports Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Nucleus Software Exports Ltd stocks is 1,378/724.
What is the Stock P/E of Nucleus Software Exports Ltd?
The Stock P/E of Nucleus Software Exports Ltd is 16.3.
What is the Book Value of Nucleus Software Exports Ltd?
The Book Value of Nucleus Software Exports Ltd is 304.
What is the Dividend Yield of Nucleus Software Exports Ltd?
The Dividend Yield of Nucleus Software Exports Ltd is 1.27 %.
What is the ROCE of Nucleus Software Exports Ltd?
The ROCE of Nucleus Software Exports Ltd is 22.6 %.
What is the ROE of Nucleus Software Exports Ltd?
The ROE of Nucleus Software Exports Ltd is 16.8 %.
What is the Face Value of Nucleus Software Exports Ltd?
The Face Value of Nucleus Software Exports Ltd is 10.0.